|
FDA OKs Pfizer’s Lyrica to Treat Neuropathic Pain Due to Spinal Cord Injury
The FDA has approved an expanded indication for Pfizer’s Lyrica CV to treat neuropathic pain due to spinal cord injury, boosting the pharma giant’s fast-growing pain management portfolio.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives